TerrAscend (TSNDF) Other Non-Current Liabilities (2020 - 2026)

TerrAscend's (TSNDF) quarterly Other Non-Current Liabilities came in at $1.7 million in Q1 2026, up 289.91% year-on-year from $446000.0 in Q1 2025, and down 45.45% on a QoQ basis from $3.2 million in Q4 2025.

TerrAscend (TSNDF) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 7 years of Other Non-Current Liabilities data on file, last reported at $1.7 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 289.91% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 289.91% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 606.87% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $1.7 million, down from $3.2 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for TSNDF reached as high as $15.8 million in Q1 2023 and fell as low as $86000.0 in Q3 2025.
  • Historically, Other Non-Current Liabilities has averaged $3.4 million across 5 years, with a median of $2.1 million in 2024.
  • Across the five-year window, Other Non-Current Liabilities soared 1065.83% in 2023 and slumped 95.02% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $711000.0 in 2022, then soared by 626.02% to $5.2 million in 2023, then plunged by 91.26% to $451000.0 in 2024, then soared by 606.87% to $3.2 million in 2025, then slumped by 45.45% to $1.7 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.7 million in Q1 2026, $3.2 million in Q4 2025, and $86000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.74 Mn
Dec 31, 2025 3.19 Mn
Sep 30, 2025 86,000.00
Jun 30, 2025 178,000.00
Mar 31, 2025 446,000.00
Dec 31, 2024 451,000.00
Sep 30, 2024 1.73 Mn
Jun 30, 2024 2.11 Mn
Mar 31, 2024 6.08 Mn
Dec 31, 2023 5.16 Mn
Sep 30, 2023 7.92 Mn
Jun 30, 2023 5.75 Mn
Mar 31, 2023 15.84 Mn
Dec 31, 2022 711,000.00
Sep 30, 2022 679,000.00
Jun 30, 2022 2.62 Mn
Mar 31, 2022 3.40 Mn
Dec 31, 2021 2.55 Mn
Dec 31, 2020 132.26 Mn